SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001371796-19-000001
Filing Date
2019-02-11
Accepted
2019-02-11 14:01:52
Documents
1
Effectiveness Date
2019-02-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8694
  Complete submission text file 0001371796-19-000001.txt   9710
Mailing Address 135 NEWBURY STREET FRAMINGHAM MA 01701
Business Address 135 NEWBURY STREET FRAMINGHAM MA 01701 508-283-1200
Solace Therapeutics Inc (Filer) CIK: 0001371796 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-332570 | Film No.: 19584468